Quality of Life and Toxicities Following Whole-Palm vs. Involved-Field Radiotherapy for Dupuytren’s Disease: A Sub-Study from a Randomized Trial
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S85
DOI: 10.1016/j.ijrobp.2026.06.099 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von R. Duvenage und 17 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Duvenage, R., Martin, J., Burgess, T., McClelland, B., Christie, D., Werker, P., Rozen, W., Steenbakkers, R., Haan, A. D., Anoora, S., Sandoz, D., Sappiatzer, J., Neville, K., Sampaio, S., Schlect, D., Bucci, J., Hunter-Smith, D., & Dilley, D. (2026). Quality of Life and Toxicities Following Whole-Palm vs. Involved-Field Radiotherapy for Dupuytren’s Disease: A Sub-Study from a Randomized Trial. International Journal of Radiation Oncology*Biology*Physics, 126(1), S85. https://doi.org/10.1016/j.ijrobp.2026.06.099
Vancouver
Duvenage R, Martin J, Burgess T, McClelland B, Christie D, Werker P, et al. Quality of Life and Toxicities Following Whole-Palm vs. Involved-Field Radiotherapy for Dupuytren’s Disease: A Sub-Study from a Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S85. doi:10.1016/j.ijrobp.2026.06.099
BibTeX
@article{Duvenage2026,
author = {Duvenage, R. and Martin, J.M. and Burgess, T. and McClelland, B. and Christie, D. and Werker, P.M.N. and Rozen, W. and Steenbakkers, R.J.H.M. and Haan, A. de and Anoora, S. and Sandoz, D. and Sappiatzer, J. and Neville, K. and Sampaio, S. and Schlect, D. and Bucci, J. and Hunter-Smith, D. and Dilley, D.},
title = {Quality of Life and Toxicities Following Whole-Palm vs. Involved-Field Radiotherapy for Dupuytren’s Disease: A Sub-Study from a Randomized Trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S85},
doi = {10.1016/j.ijrobp.2026.06.099}
}
EUVIMED